A Phase 2 Study to Assess the Pharmacokinetics of Bevirimat 100 mg Tablets Given to HIV-1 Positive Patient for 15 Days

Clinical trial NCT01097070 · COMPLETED

Trial details

NCT number: NCT01097070
Sponsor: Myrexis Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2008-11-01
Primary completion: 2009-01-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.